Viaskin Peanut Patch BLA accepted
The FDA has accepted the BLA for the Viaskin Peanut Patch. This is a key step in the process of getting FDA approval for this revolutionary treatment.
DBV Technologies, the French company developing the peanut patch, has been on a roller coaster over the last few years. In total, Viaskin Peanut has performed 8 clinical trials on human subjects, involving over 1,000 patients and their families. Patient interest continues to grow, which means increased media visibility. That also means that they’ve received uncomfortable bad press during routine scientific setbacks.
The road to FDA approval is long, and it’s normal for treatments encounter problems along the way. Failure is part of the scientific process, and is always a learning experience.Read the full blog post here!